Evaluation of efficacy and safety of Vardenafil in patients with erectile dysfunction and type 1 diabetes
Asses efficacy of Vardenafil in patients with type 1 diabetes and erectile dysfunction
- Men >/= 18 years of age, with 6 months or longer diagnosis of ED as defined by NIH Consensus statement, - Diabetes type 1 - Stable sexual relationship for > 6 month.
- Primary hypoactive sexual desire - History of myocardial infarction, stroke or life-threatening arrhythmia within prior 6 month - Nitrate therapy
Many locations, Germany
E-mail: [email protected]
Phone: Not Available
A rand, db, parallel-group, plac-controlled study evaluating the efficacy and safety of vardenafil administered for 12 weeks in a flexible-dose regimen compared to plac in men with diabetes mellitus type 1 and erectile dysfunction